tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CADL Stock Latest News

Three new option listings on April 15th
The FlyThree new option listings on April 15th
4d ago
CADL
DXYZ
Candel Therapeutics Gains Orphan Drug Status for Cancer Treatment
PremiumCompany Announcements
Candel Therapeutics Gains Orphan Drug Status for Cancer Treatment
8d ago
8K
CADL
Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer
PremiumPress Releases
Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer
8d ago
CADL
Candel Therapeutics announces U.S. FDA granted ODD to CAN-2409
PremiumThe Fly
Candel Therapeutics announces U.S. FDA granted ODD to CAN-2409
8d ago
CADL
Candel Therapeutics Unveils Breakthrough Immunotherapy Candidate
PremiumCompany Announcements
Candel Therapeutics Unveils Breakthrough Immunotherapy Candidate
10d ago
8K
CADL
Candel Therapeutics presents preclinical data on immunotherapy candidate
PremiumThe FlyCandel Therapeutics presents preclinical data on immunotherapy candidate
10d ago
CADL
Candel Therapeutics Presents Preclinical Data at AACR on Immunotherapy Candidate for Induction of Tertiary Lymphoid Structures in Solid Tumors
PremiumPress Releases
Candel Therapeutics Presents Preclinical Data at AACR on Immunotherapy Candidate for Induction of Tertiary Lymphoid Structures in Solid Tumors
10d ago
CADL
Candel Therapeutics’ treatment of pancreatic cancer receives orphan designation
PremiumThe Fly
Candel Therapeutics’ treatment of pancreatic cancer receives orphan designation
11d ago
CADL
Candel Therapeutics Inc trading resumes
PremiumThe Fly
Candel Therapeutics Inc trading resumes
14d ago
CADL
Candel Therapeutics Inc trading halted, volatility trading pause
PremiumThe Fly
Candel Therapeutics Inc trading halted, volatility trading pause
14d ago
CADL
Candel Therapeutics Shows Promising Pancreatic Cancer Trial Results
PremiumCompany Announcements
Candel Therapeutics Shows Promising Pancreatic Cancer Trial Results
15d ago
8K
CADL
Candel Therapeutics announces interim data from Phase 2 trial of CAN-2409
PremiumThe Fly
Candel Therapeutics announces interim data from Phase 2 trial of CAN-2409
15d ago
CADL
Candel Therapeutics presents updated data from Phase 1b trial of CAN-3110
PremiumThe FlyCandel Therapeutics presents updated data from Phase 1b trial of CAN-3110
22d ago
CADL
Candel Therapeutics Announces Oral Presentation During the 5th Glioblastoma Drug Development Summit with Update on Phase 1b Clinical Trial of CAN-3110 in Recurrent High-Grade Glioma
PremiumPress Releases
Candel Therapeutics Announces Oral Presentation During the 5th Glioblastoma Drug Development Summit with Update on Phase 1b Clinical Trial of CAN-3110 in Recurrent High-Grade Glioma
22d ago
CADL
Candel Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Highlights
PremiumPress Releases
Candel Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Highlights
22d ago
CADL
Candel Therapeutics reports Q4 EPS (38c) vs (18c) last year
PremiumThe Fly
Candel Therapeutics reports Q4 EPS (38c) vs (18c) last year
22d ago
CADL
Is CADL a Buy, Before Earnings?
PremiumPre-Earnings
Is CADL a Buy, Before Earnings?
25d ago
CADL
Candel Therapeutics Unveils Immunotherapy Breakthrough at AACR
PremiumCompany Announcements
Candel Therapeutics Unveils Immunotherapy Breakthrough at AACR
1M ago
8K
CADL
Candel Therapeutics Gains FDA Fast Track for Brain Cancer Treatment
PremiumCompany Announcements
Candel Therapeutics Gains FDA Fast Track for Brain Cancer Treatment
2M ago
8K
CADL
CAN-3110 Receives FDA Fast Track Designation for Treatment of Recurrent High-Grade Glioma
PremiumPress ReleasesCAN-3110 Receives FDA Fast Track Designation for Treatment of Recurrent High-Grade Glioma
2M ago
CADL
Candel Therapeutics announces CAN-3110 received U.S. FDA FTD
PremiumThe Fly
Candel Therapeutics announces CAN-3110 received U.S. FDA FTD
2M ago
CADL
Candel Therapeutics provides update on upcoming milestones
PremiumThe Fly
Candel Therapeutics provides update on upcoming milestones
2M ago
CADL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >